Mefruside
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| ATC code | C03BA05 (WHO) |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number |
7195-27-9 |
| PubChem (CID) | 4047 |
| ChemSpider |
3907 |
| UNII |
X1NS9SNS92 |
| KEGG |
D01877 |
| ECHA InfoCard | 100.027.785 |
| Chemical and physical data | |
| Formula | C13H19ClN2O5S2 |
| Molar mass | 382.88 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| | |
Mefruside (INN) is a diuretic indicated for the treatment of edema and hypertension.[1]
It was developed by Bayer A.G. and is sold under the tradename Baycaron.
References
- ↑ Allen HB, Lee DA (1973). "A general practice assessment of mefruside ('Baycaron') in the treatment of oedema and hypertension". Curr Med Res Opin. 1 (9): 547–53. doi:10.1185/03007997309111720. PMID 4779251.
This article is issued from Wikipedia - version of the 5/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
